NovoCure Limited - Ordinary Shares (NVCR)

Novocure Ltd is a biotechnology company that focuses on developing and commercializing innovative treatments for cancer

The company's primary technology is Tumor Treating Fields (TTFields), a non-invasive therapy that utilizes electric fields to disrupt cancer cell division and inhibit tumor growth. Novocure partners with healthcare providers to bring its advanced therapies to patients suffering from various types of tumors, particularly aggressive forms of cancer. Through ongoing research and collaboration, Novocure aims to improve treatment options and outcomes for patients battling cancer, employing a unique approach that integrates with existing treatment modalities.